Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « emerging »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
emerges < emerging < emetine  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000089 (2020) Jacob J. Adashek [États-Unis] ; Shumei Kato [États-Unis] ; Scott M. Lippman [États-Unis] ; Razelle Kurzrock [États-Unis]The paradox of cancer genes in non-malignant conditions: implications for precision medicine
000097 (2020) Weiyi Tan ; Jamil AboulhosnThe cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000113 (2020) José M. Carballido [Suisse] ; Camille Regairaz [Suisse] ; Celine Rauld [Suisse] ; Layla Raad [Suisse] ; Damien Picard [Suisse] ; Michael Kammüller [Suisse]The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases
000114 (2020) Pia M. Vidal [Chili] ; Rodrigo Pacheco [Chili]The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia
000121 (2020) Mattia Rosso [États-Unis] ; Shrishti Saxena [États-Unis] ; Tanuja Chitnis [États-Unis]Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options.
000153 (2020) Luca Perico ; Ariela Benigni ; Giuseppe RemuzziShould COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade
000167 (2020) Peter A. Riedell ; Michael R. BishopSafety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas
000178 (2020) Adelaide Sofia Batalha Figueiredo [Portugal] ; Ana Luísa Oliveira [Portugal] ; Ant Nio Caetano [Portugal] ; Maria Francisca Moraes-Fontes [Portugal]SAPHO: has the time come for tailored therapy?
000187 (2020) Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000223 (2020) Chih-Chia Lu [République populaire de Chine] ; Mei-Yu Chen [République populaire de Chine] ; Yuh-Lih ChangPotential therapeutic agents against COVID-19: What we know so far
000225 (2020) Ali Rismanbaf [Iran]Potential Treatments for COVID-19; a Narrative Literature Review
000268 (2020) Muhammad Khan [République populaire de Chine] ; Sumbal Arooj [Pakistan] ; Hua Wang [République populaire de Chine]NK Cell-Based Immune Checkpoint Inhibition
000305 (2020) Susanne H. C. Baumeister [États-Unis] ; Benedetta Rambaldi [États-Unis, Italie] ; Roman M. Shapiro [États-Unis] ; Rizwan Romee [États-Unis]Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
000342 (2020) Cinnie Yentia Soekojo ; Melissa Ooi ; Sanjay De Mel ; Wee Joo ChngImmunotherapy in Multiple Myeloma
000360 (2020) Sebastian Birndt [Allemagne] ; Thomas Schenk [Allemagne] ; Babett Heinevetter [Allemagne] ; Frank M. Brunkhorst [Allemagne] ; Georg Maschmeyer [Allemagne] ; Frank Rothmann [Allemagne] ; Thomas Weber [Allemagne] ; Markus Müller [Allemagne] ; Jens Panse [Allemagne] ; Olaf Penack [Allemagne] ; Roland Schroers [Allemagne] ; Jan Braess [Allemagne] ; Norbert Frickhofen [Allemagne] ; Stephan Ehl [Allemagne] ; Gritta Janka [Allemagne] ; Kai Lehmberg [Allemagne] ; Mathias W. Pletz [Allemagne] ; Andreas Hochhaus [Allemagne] ; Thomas Ernst [Allemagne] ; Paul La Rosée [Allemagne]Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry
000397 (2020) Andrei A. Deviatkin ; Yulia A. Vakulenko [Russie] ; Ludmila V. Akhmadishina ; Vadim V. Tarasov ; Marina I. Beloukhova ; Andrey A. Zamyatnin Jr. [Russie] ; Alexander N. LukashevEmerging Concepts and Challenges in Rheumatoid Arthritis Gene Therapy
000398 (2020) L Rke J. B. Brandt [Danemark] ; Mike B. Barnkob [Danemark] ; Yale S. Michaels [Canada] ; Julia Heiselberg [Danemark] ; Torben Barington [Danemark]Emerging Approaches for Regulation and Control of CAR T Cells: A Mini Review
000468 (2020) Erin K. Mccreary [États-Unis] ; Jason M. Pogue [États-Unis]Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
000528 (2020) Ye Yi ; Philip N. P. Lagniton ; Sen Ye ; Enqin Li ; Ren-He XuCOVID-19: what has been learned and to be learned about the novel coronavirus disease
000553 (2020) Akbarshakh Akhmerov ; Eduardo MarbánCOVID-19 and the Heart
000554 (2020) Sevim Zaim [Royaume-Uni] ; Jun Heng Chong [Royaume-Uni] ; Vissagan Sankaranarayanan [Royaume-Uni] ; Amer Harky [Royaume-Uni]COVID-19 and Multi-Organ Response

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "emerging" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "emerging" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    emerging
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021